Curcumin in Management of Chronic Obstructive Pulmonary Disease

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: COPD

In brief

In this double-blind, placebo-controlled trial, 120 patients with a diagnosis of COPD will be randomized to receive either a daily curcumin preparation or placebo for 90 days, in addition to the standard of care treatment. The outcomes will be compared between the study arms. No dose escalation will be used.

Key facts

Study ID
NCT04687449
Run by
Danbury Hospital
People needed
120
Starts
2022-01-01
Expected to finish
2023-12-15
Last updated by the study team
2021-07-09

Who can join

Age: 40 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.